• Mashup Score: 1
    Source: Twitter
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      Thanks, @ACCinTouch, for the opportunity to write an expert analysis on "Microvascular Thrombi in COVID-19" with @OSUWexMed's @RamiKahwash! Read Here: https://t.co/Kvmjm8mms6 #CardioTwitter #ACCFIT #CardioOnc https://t.co/ywaQCN2oVH

  • Mashup Score: 2
    Cardio-Oncology Symposium - 4 year(s) ago

    New innovations in cancer treatment are improving cancer survival. However, some of these new treatments have new or unexpected cardiovascular toxicities.  Many cancer survivors are now living longer,

    Source: OSU Center for Continuing Medical Education
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      Did you miss the @OSUWexMed & @OSUCCC_James #CardioOncology Symposium Live Expert Panel? It's available now at https://t.co/9TGPvXsrWq! Register for free access to modules w expert talks, cases, & panels. @md_addison @OSUCardioOnc @RRBaligaMD @maryam_lustberg @AjayVallakati https://t.co/a4tbYn2Ima

  • Mashup Score: 1
    Cardio-Oncology Symposium - 4 year(s) ago

    New innovations in cancer treatment are improving cancer survival. However, some of these new treatments have new or unexpected cardiovascular toxicities.  Many cancer survivors are now living longer,

    Source: OSU Center for Continuing Medical Education
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      Excellent @OSUWexMed & @OSUCCC_James #CardioOnc Symposium Opening Panel this afternoon. Thank you to UCLA's @datsunian, & our OSU experts. Great audience Q&A! Panel recording available soon at https://t.co/9TGPvXsrWq. Register for access to three on-demand modules! https://t.co/8cTgDbpciB

  • Mashup Score: 3
    Cardio-Oncology Symposium - 4 year(s) ago

    New innovations in cancer treatment are improving cancer survival. However, some of these new treatments have new or unexpected cardiovascular toxicities.  Many cancer survivors are now living longer,

    Source: OSU Center for Continuing Medical Education
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      Announcing our 2020 #CardioOncology❤️Symposium! Launching 3 #OnDemand modules with talks by @OSUWexMed & @OSUCCC_James stars💫+ amazing guest faculty🤩. Don't miss the LIVE opening panel Friday Dec 18 at 3:30 pm EST! Full agenda & FREE registration: https://t.co/9TGPvXsrWq https://t.co/A3KNiTHcZY

  • Mashup Score: 5
    Cardiovascular Complications of Prostate Cancer Therapy - 4 year(s) ago

    With treatment advances, the most common cause of death in prostate cancer patients is cardiovascular disease. Discerning the contribution of prostate cancer treatment on cardiovascular complications versus the natural progression of cardiovascular disease remains an ongoing area of investigation. Evaluating the research and identifying opportunities for further investigation is critical for…

    Source: Current Treatment Options in Cardiovascular Medicine
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      Many unanswered #CardioOnc❓about prostate cancer 🎗️therapy ➡️Cardiac risk factor control ➡️Specific drug toxicities & best therapy choice ➡️Radiation therapy risks ➡️Optimal CV monitoring ➡️Approach to adverse CV events & CV interventions Read more: https://t.co/8MP3ZMn1f3 https://t.co/x7M3IAIYhQ

    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      Happy to share our just-published review! 🎉 Cardiovascular Complications of Prostate Cancer Therapy Read here: https://t.co/8MP3ZMn1f3 I learned so much from our urology and oncology co-authors and the excellent #CardioOnc ♥️ mentorship of @avirupguha & @arjunkg! Thank you🙏! https://t.co/x58RnhM6YZ

  • Mashup Score: 1
    Mitochondrial pyruvate carriers are required for myocardial stress adaptation - 4 year(s) ago

    Metabolic substrate partitioning underlies myocardial homeostatic capacity and adaptation to stress. Zhang et al. show that decreasing mitochondrial pyruvate carrier expression redirects glycolytic intermediates and leads to heart failure, which is prevented or reversed with a high-fat or ketogenic diet.

    Source: Nature Metabolism
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CampbellMDPhD
      CampbellMDPhD

      @IntMedAbel discusses parallels of LV ♥️ remodeling/metabolism w cancer met in his recent @NatMetabolism: https://t.co/ebqQGkJ7fc -LV remodeling depends on glycolytic met pathways -Aberrant 2-hydroxyglutarate met in stress response ➡️LV remodeling #AHA20 #CardioOncology 2/7 https://t.co/cuwj7ZfDYU

Load More